Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). - Wikidata - awgldk - TriplyDB

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

http://www.wikidata.org/entity/Q33672480

about

Strategies for combining immunotherapy with radiation for anticancer therapy Killer immunoglobulin-like receptors and tumor immunity The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells NK cell-based immunotherapy for malignant diseases.An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma.Human herpesviridae methods of natural killer cell evasion Highly activated and expanded natural killer cells for multiple myeloma immunotherapy Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation.Effects of DDT and triclosan on tumor-cell binding capacity and cell-surface protein expression of human natural killer cells.Activation of protein kinase C and protein kinase D in human natural killer cells: effects of tributyltin, dibutyltin, and tetrabromobisphenol A.Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms.Tributyltin and dibutyltin alter secretion of tumor necrosis factor alpha from human natural killer cells and a mixture of T cells and natural killer cells The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing.Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.HLA-G expression and role in advanced-stage classical Hodgkin lymphoma.Natural killer cells and their receptors in multiple sclerosis.Killer Immunoglobulin-like Receptors (KIR) haplogroups A and B track with Natural Killer Cells and Cytokine Profile in Aged Subjects: Observations from Octo/Nonagenarians in the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST).Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.Combination immune therapies to enhance anti-tumor responses by NK cells.Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity.KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations.Natural killer cells: a review of manufacturing and clinical utility.Role of KIR3DS1 in human diseases.Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?The colorectal cancer immune microenvironment and approach to immunotherapies.Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity.Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma.Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer.Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity.Rhesus macaque KIR bind human MHC class I with broad specificity and recognize HLA-C more effectively than HLA-A and HLA-B Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor.

P2860

Q26796675-5592FC4E-C309-4611-A9D4-815086DB89F4 Q27005792-CCAA87F9-F0D5-4E44-8DD1-774ACA3267CA Q27022789-7035FAF1-E7E6-445E-95C4-6AD252A884FD Q28081338-4C40AF7C-181B-488D-B9A6-B358BF703628 Q28743223-89747D24-E592-4148-BC07-CCC8D5F620C3 Q33827433-3D7E9AF2-4BA7-4948-B879-88EA8DFEB159 Q34786615-3A90E591-F56E-4EDB-AF24-02E355E9A44A Q35556765-284DDDBC-6A85-40F4-9D36-68A582F9DBD3 Q35963440-2E748CB6-34F9-4E82-B665-B10A08682E94 Q36102137-FE3162E4-D587-4005-9640-5BBE390CE69B Q36216203-F3942A39-BD2D-43F3-871A-B45F875C0F1F Q36228510-670D44E3-86E7-4B26-93FD-59B90C963CF5 Q36282216-F3BEFD39-7632-400B-9AB7-9E4D7E1D9628 Q36289164-C01AB109-DE66-4E33-9F21-73F5BBE02349 Q36471507-69B8F2E4-E1A3-4169-B055-627BF5622C8E Q36569959-9658C0A0-8207-401D-826B-22855E0748E7 Q36605357-5476F6D8-17F5-4142-B0BE-7E4D055E88E6 Q36691438-0D7C4D84-5DDE-4556-BF60-63B149B7509E Q36821228-5CB6F144-8765-452B-A6F8-94B7D5CC8337 Q36990211-19FA784B-0F60-4ACC-88F5-6366A340FFA9 Q37067425-E01E6A59-D9B3-4E40-A678-77D1BD6A0397 Q37124504-0B4F6776-9602-40FE-B6A8-6E9EDA3FC523 Q37308200-4F8BB321-7E9B-44A6-ABA3-CA12FD0861F0 Q37332652-E05353D0-B955-4AB6-A5EF-8AC53BC83AFD Q37408550-FE83EC18-E199-4CFE-BAB6-83CE04263927 Q37434670-ECC91BF1-B2CE-4231-9AAC-774216AE5B66 Q37696089-FFAF4640-750A-4B7E-8542-B3CCF684C07C Q37826770-C6A74602-923E-4D35-A0C2-6914070A8D02 Q38016470-59D82C8A-058D-463F-9411-3CA8575ED8F2 Q38057745-294EE414-3E0A-4D35-B386-A06AF821556F Q38148501-95D0D1C9-B071-488E-A715-B6A2F69CA62F Q38366141-F80AA568-174D-4C5F-B9B8-D7B8DEE5059A Q38638847-B499CB71-754E-4180-A49C-643773208FD3 Q38713604-42A447E1-2755-4DAE-9526-E690185693D9 Q39190801-3488717E-D7C7-45B5-A419-D93D79C5D5C7 Q41913332-BBD92AE5-0E87-44BE-A0EC-D1746E529989 Q42316239-8A410221-0E77-4C7D-B221-46FAAB1686F7 Q42544946-6E178C64-AB2D-4357-99B8-5D90788166B5 Q42582499-0F41D771-9D65-41CD-B54B-350940725AEF Q47111488-DD583933-CD8E-41F6-B017-9477FA784FCC

P2860

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

http://www.wikidata.org/entity/Q33672480

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

@ast

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

@en

type

label

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

@ast

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

@en

prefLabel

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

@ast

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

@en

P1433

Q33672480-1708BF11-0D10-4290-8D46-741890C2C31B

P1476

Q33672480-3D31E400-F0D4-40D2-9AFB-451C80A7B32F

P2093

Q33672480-12A56D8F-340D-451B-ADF7-093232768A10

Q33672480-12F71FF2-0F6A-4CD8-8944-C7BCEC4D5CCB

P2860

Q33672480-0016341D-BBF6-40E2-8E86-3B54FEB089D8

Q33672480-0F4EA49F-09FE-461E-B517-2FBC33EEAA89

Q33672480-144D99CF-89B8-4584-91B2-CDA1B334729E

Q33672480-1497644F-CD4D-4154-8C63-90F280B163C6

Q33672480-15BE5036-8B75-456A-802E-FC079A418AD5

Q33672480-18048B7B-E73E-43CD-A684-571497F6E376

Q33672480-18CABD5A-9017-4C48-8F34-CD672174D2F5

Q33672480-190788EA-2D0E-4C21-8909-750440A2F09E

Q33672480-19493027-A6E9-4E50-90B2-48C415D97BAA

Q33672480-1A000E1B-D54B-417A-9D10-05948C995E22

P304

Q33672480-ABE3F083-C8F8-4D41-AB9C-1769160E33FD

P31

Q33672480-A9491F8C-ED8C-4AA0-993E-76EEC2BDFEDA

P356

Q33672480-7B36F6A6-A2B5-4CDB-AF22-BA50E16DEA4F

P433

Q33672480-4DBB3127-9FE3-4F41-91B1-AB37DF332AE4

P478

Q33672480-386539EC-DCDB-46BA-98CB-FF5A28E0B61E

P577

Q33672480-0513262D-16DF-47A8-954E-CFD07F7F36C6

P5875

Q33672480-0D76EF51-23D8-4494-B5FC-90CDA5BB59A2

P698

Q33672480-3BB9C5FE-8F64-4BC0-A1CC-9A65C73E4C88

P932

Q33672480-FE116157-586C-4AD5-A55A-F0B8304D0D7F

P356

P1433

Cancer Biology and Therapy

P1476

Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).

@en

P2093

Amanda K Purdy

http://www.w3.org/2001/XMLSchema#string

Kerry S Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C

Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.

T cell activation

The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer

NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules

Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)

Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells

P304

2211-2220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.8.23.10455

http://www.w3.org/2001/XMLSchema#string

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38099628

http://www.w3.org/2001/XMLSchema#string

P698

19923897

http://www.w3.org/2001/XMLSchema#string

P932

2825280

http://www.w3.org/2001/XMLSchema#string